期刊文献+

维生素E对醛固酮诱导的大鼠心肌重构及氧化应激的干预作用 被引量:4

Vitamin E reduces the oxidative stress and myocardial remodeling induced by aldosterone
原文传递
导出
摘要 目的:观察外源性醛固酮(aldosteronre,Ald)灌注对大鼠心肌重构和氧化应激水平的影响,以及抗氧化剂维生素E(VitE)的干预作用。方法:大鼠随机分为:①对照组,②Ald组,③Ald+VitE组和④Ald+螺内酯(spironolactone,Spi)组。用黄嘌呤氧化法测定超氧化物歧化酶的活性,用巴比妥酸比色法测定丙二醛的含量,Masson三色法检测心肌胶原,细胞凋亡原位检测法检测心肌细胞凋亡。结果:与Ald组比较,Ald+VitE组心肌胶原、凋亡指数、丙二醛明显减少,超氧化物歧化酶明显增加(P<0.05)。Ald+VitE组与Ald+Spi组上述指标差异无统计学意义。结论:VitE能够降低Ald诱导的大鼠心肌氧化应激水平,显著改善心肌纤维化和心肌细胞凋亡。 Objective:To investigate the oxidative stress and myocardial remodeling induced by aldosterone (Ald) in rats and the intervention of Vitamin E (Vit E). Method:Rats were divided into 4 groups randomly: ①Control group,②Ald group,③Ald+VitE group,④Ald+Spi group. The SOD and MDA were detected by zanthine hydrocarbonylation and malonylurea colourinetry,respectively.Cardiac collagen and apoptosis were detected by Masson trichromatism and TUNEL methods,respectively. Result:Compared with Ald group,SOD increased,MDA,cardiac collagen and AI decreased significantly in Ald+VitE group. There was no significant difference between Ald+VitE and Ald + Spi group. Conclusion:Vitamin E can reduce oxidative stress,myocardial fibrosis and apoptosis induced by aldosterone and improve myocardial remodeling in rats.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第9期686-689,共4页 Journal of Clinical Cardiology
基金 安徽省优秀青年基金项目资助(No:04043054)
关键词 氧化应激 醛固酮 心肌重构 细胞凋亡 维生素E oxidative stress aldosterone myocardial remodeling cardiac apoptosis vitamin E
  • 相关文献

参考文献8

  • 1孙建琦,马礼坤.醛固酮-氧化应激与心肌重构研究进展[J].心血管病学进展,2008,29(5):704-706. 被引量:17
  • 2KUSTER G M, KOTLYAR E, RUDE M K, et al. Mineralocortieoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload[J]. Circulation,2005, 111 :420--427.
  • 3RUDE K M, DUHANEY S T, KUSTER M G, et al. Aldosterone stimulates matrix rnetalloproteinases and reactive oxygen species in adult rat ventricular cardiornyocytes [J]. Hypertension, 2005, 46: 555-- 561.
  • 4KOBAYASHI N, YOSHIDA K, NAKANO S, et al. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts[J]. Hypertension, 2006,46 : 671 -- 679.
  • 5ONOGI H, MINATOGUCHI S, CHEN X H, et al Edaravone reduces myocardial infarct size and im proves cardiac function and remodelling in rabbits[J].Clin Exp Pharmacol Physiol,2006 , 33 :1035--1041.
  • 6YOSHIDA K, KIM-MITSUYAMA S, WAKE R, et al. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress[J].Hypertens Res,2005, 28:447--455.
  • 7NAKAMURA R, EGASHIRA K, MACHIDA Y, et al. Probucol attenuates left ventricular dysfunction and remodeling in tachyeardia-induced heart failure: roles of oxidative stress and inflammation [J].Circu lation,2002 ,106:362--367.
  • 8QIN F, YAN C, PATEL R, et al. Vitamins C and E attenuate apoptosis, beta-adrenergic receptor desensitization, and sarcoplasmic reticular Ca2 + ATPase downregulation after myocardial infarction[J].Free Radic Biol Med, 2006,40 :1827 -- 1842.

二级参考文献21

  • 1Stas S, Whaley-Connell A, Habibi J, et al. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling. [ J ]. Endocrinology, 2007,148 ( 8 ) : 3773 -3780.
  • 2Johar S, Cave AC, Narayanapanicker A, et al. Aldosterone mediates angiotensin Ⅱ-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase [ J ]. FASEB J, 2006,20 (9) : 1546-1548.
  • 3Luther JM, Gainer JV, Murphey LJ,et ah Angiotensin Ⅱ induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism [ J ]. Hypertension ,2006,48 ( 6 ) : 1050-1057.
  • 4Paul M, Noeleen D, Catherine RM, et al. Spironolactone reduces fibrosis of dilated atria dining heart failure in rats with myocardial infarction [ J ]. Eur Heart J, 2005,26 (20) :2193-2199.
  • 5Kuster GM, Kotlyar E, Rude MK, et al. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload [ J ]. Circulation, 2005,111 (4) :420-427.
  • 6Sanz-Rosa D, Oubina MP, Cediel E, et al. Eplerenone reduces oxidative stress and enhances eNOS in SHR : vascular functional and structural consequences [ J ]. Antioxid Redox Signal,2005,7 ( 9-10 ) : 1294-1301.
  • 7Park YM,Park MY,Suh YL, et al. NAD (P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats [J]. Biochem Biophys Res Commun,2004,313(3) :812-817.
  • 8Kotlyar E, Vita JA, Winter MR, et al. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure [ J ]. J Card Fail,2006,12 ( 2 ) : 122-127.
  • 9Ahokas RA, Wariington K J, Gerling IC,et al. Aldosteronism and peiipheral blood mononuclear cell activation : a neuroendocrine-immune interface [ J ]. Circ Res, 2003,93(10) :e124-e135.
  • 10Zhang A, Jia Z, Guo X, et al. Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin [ J 1. Am J Physiol Renal Physiol, 2007,293(3) :17723-731.

共引文献16

同被引文献51

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部